Atlas Trials

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL

Clinical trial NCT01750567 · COMPLETED

Trial details

NCT number
NCT01750567
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed Chronic Lymphocytic Leukemia
Start date
2012-11-01
Primary completion
2025-02-28
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.